These side effects ended up notably milder in comparison to an inhibitor of the two bromodomains. A detailed molecular analysis also exposed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor 88 These preclinical studies offer paradigms for future clinical trials in AML, and using https://barrye422nzj5.wikissl.com/user